Barclays
XTNT icon

Barclays’s Xtant Medical Holdings XTNT Stock Holding History

Barclays’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8
Closed -$5 – 5767
2025
Q3 		$5 Buy
+8
New +$5 ﹤0.01% 5416
2021
Q2 		– Sell
-2,951
Closed -$7K – 5108
2021
Q1 		$7K Buy
+2,951
New +$6.3K ﹤0.01% 4472
2020
Q3 		– Sell
-20
Closed – – 5635
2020
Q2 		$0 Buy
+20
New +$18 ﹤0.01% 6339
2018
Q4 		– Sell
-2
Closed – – 7394
2018
Q3 		$0 Sell
2
-388
-99% -$2.05K ﹤0.01% 7438
2018
Q2 		$2K Buy
+390
New +$2.61K ﹤0.01% 6854

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barclays's XTNT Position: Q4 2025 in Review

Barclays sold out of Xtant Medical Holdings (XTNT) in Q4 2025, closing a stake of 8 shares — an estimated $5 sold.

Barclays first reported a position in XTNT in Q2 2018 and held it in 5 quarters. The position peaked at $7K in Q1 2021. 35 funds tracked by Wall St. Rank hold XTNT as of Q4 2025.

  • Barclays reported no remaining Xtant Medical Holdings position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 8 Xtant Medical Holdings shares in Q4 2025, an estimated $5.
  • Barclays first reported a position in Xtant Medical Holdings in Q2 2018 and held it in 5 quarters.
  • Barclays's Xtant Medical Holdings position peaked at $7K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.